ARCA:PBE

Invesco Biotechnology & Genome ETF

$ 65.99 0.6058 ( +0.93%) 12:35 PM EST
PE Ratio:
41.23
PB Ratio:
3.53
Volume:
1.80K
Dividend Yield %:
0.35
Last Holding update 2025-06-29 30 Stocks (2 new)
Value $221.00 Mil Turnover 12 %
Portfolio Report
Registrant: Invesco Biotechnology & Genome ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Invesco Biotechnology & Genome ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Invesco Biotechnology & Genome ETF Key Statistics

Name Value
Day's Open ($) 65.41
Day's Range ($) 65.41 - 65.99
Day's Volume 1,796
52-Week Range ($) 54.52 - 72.84
Beta 0.82
3-Year Sharpe Ratio 0.05
3-Year Sortino Ratio 0.07
Volatility 14.66
14-Day RSI 52.91
14-Day ATR ($) 1.012044
20-Day SMA ($) 64.88736

Fundamental Data

Name Value
Market Cap (Mil $) 228.986
Shares Outstanding (Mil) 3.47
PE Ratio 41.23
PE Ratio (10y Range) 14.2 - 35.8
PE Ratio (10y Median) 21.74
PB Ratio 3.53
PB Ratio (10y Range) 2.94 - 5.95
PB Ratio (10y Median) 4.15

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.23
Dividend Yield % 0.35
Dividend Yield % (10y Range) 0.01 - 1.84
Dividend Yield % (10y Median) 0.1
Next Dividend Payment Date
Dividend Frequency Quarterly

PBE Invesco Biotechnology & Genome ETF Fundamental Charts

Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF

Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF

Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF

Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PBE

No Available Data

ARCA:PBE is held by these investors

No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2025-04-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
NTRA
Natera Inc
75,925
11,459.4
-2.27%
5.180
-0.12%
0.060
-1.45%
-6.51%
20,208.2
Medical Diagnostics & Research
GILD
Gilead Sciences Inc
106,203
11,314.9
-24.75%
5.110
-1.33%
0.010
+5.96%
+21.16%
137,267.6
Drug Manufacturers
NBIX
Neurocrine Biosciences Inc
102,195
11,005.4
+86.46%
4.970
+2.30%
0.100
+32.87%
-2.56%
13,162.5
Drug Manufacturers
AMGN
Amgen Inc
37,524
10,916.5
-13.62%
4.930
-0.66%
0.010
+5.88%
+15.75%
159,505.1
Drug Manufacturers
TGTX
TG Therapeutics Inc
221,180
10,065.9
+9.88%
4.550
+0.41%
0.140
+2.56%
+30.20%
6,221.6
Biotechnology
UTHR
United Therapeutics Corp
33,135
10,042.9
-4.36%
4.540
-0.21%
0.070
+4.74%
-15.34%
13,474.3
Drug Manufacturers
BIIB
Biogen Inc
82,559
9,996.2
+2.59%
4.520
+0.11%
0.060
+11.35%
-16.05%
18,809.8
Drug Manufacturers
REGN
Regeneron Pharmaceuticals Inc
16,373
9,803.5
-3.92%
4.430
-0.18%
0.020
+0.72%
-22.23%
59,642.3
Biotechnology
ILMN
Illumina Inc
123,695
9,598.7
+39.29%
4.340
+1.22%
0.080
+31.12%
-27.85%
15,261.7
Medical Diagnostics & Research
PTGX
Protagonist Therapeutics Inc
184,113
8,436.1
+20.33%
3.810
+0.64%
0.300
+24.45%
+47.67%
3,533.0
Biotechnology

Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns

Invesco Biotechnology & Genome ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
AXSM
Axsome Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.98%
95.65 ($116.78) 137.75
$110.64
-5.26%
Sold Out
0
-71,451
PTCT
PTC Therapeutics Inc
2025-04-30
New Buy
New Buy
+2.89%
39.77 ($50.25) 57.17
$48.00
-4.48%
New holding
128,294
128,294
SRPT
Sarepta Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.71%
49.3 ($84.38) 119.02
$18.25
-78.37%
Sold Out
0
-60,764
DVAX
Dynavax Technologies Corp
2025-04-30
New Buy
New Buy
+2.55%
10.31 ($12.81) 14.4
$10.60
-17.25%
New holding
481,349
481,349
INCY
Incyte Corp
2025-04-30
Reduce
Reduce
-2.53%
55.17 ($65.35) 75.26
$69.24
5.95%
Reduce -50.07%
86,742
-86,977
NBIX
Neurocrine Biosciences Inc
2025-04-30
Add
Add
+2.30%
87.54 ($112.46) 152.42
$133.00
18.26%
Add 86.46%
102,195
47,388
GILD
Gilead Sciences Inc
2025-04-30
Reduce
Reduce
-1.33%
95.48 ($107.46) 117.41
$110.35
2.69%
Reduce -24.75%
106,203
-34,937
ILMN
Illumina Inc
2025-04-30
Add
Add
+1.22%
70.3 ($88.29) 132.74
$96.41
9.20%
Add 39.29%
123,695
34,890
XNCR
Xencor Inc
2025-04-30
Add
Add
+0.89%
7.67 ($12.87) 18.28
$8.63
-32.94%
Add 67.09%
446,673
179,350
RPRX
Royalty Pharma PLC
2025-04-30
Reduce
Reduce
-0.89%
30.85 ($32.44) 33.86
$35.87
10.56%
Reduce -27.2%
191,591
-71,592

Invesco Biotechnology & Genome ETF Total Holding History ($B)

To

Invesco Biotechnology & Genome ETF's Asset Allocation

To

Invesco Biotechnology & Genome ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2025-04-30

Invesco Biotechnology & Genome ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Invesco Biotechnology & Genome ETF's Holdings Heat Map

Size field:

Invesco Biotechnology & Genome ETF's Holdings Bubble Chart

Invesco Biotechnology & Genome ETF News

  • 1

Discussions on Invesco Biotechnology & Genome ETF

User's Avatar
How would you rate this stock? PBE
No discussions yet.